Erythropoietin to treat anaemia in patients with head and neck cancer
- 1 January 2004
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 363 (9402) , 78-79
- https://doi.org/10.1016/s0140-6736(03)15183-5
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialThe Lancet, 2003
- Breast cancer trial with erythropoietin terminated unexpectedlyThe Lancet Oncology, 2003
- Erythropoietin regulates tumour growth of human malignanciesCarcinogenesis: Integrative Cancer Research, 2003
- A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003Published by Elsevier ,2000